Dolby Laboratories (DLB) Tops Q3 EPS by 24c
Tweet
Share
E-mail
Get Alerts DLB Hot Sheet
Price: $79.58 --0%
EPS Growth %: -19.8%
Financial Fact:
Total operating expenses: 173.69M
Today's EPS Names:
UXIN, TOWN, NRIM, More
EPS Growth %: -19.8%
Financial Fact:
Total operating expenses: 173.69M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.71, $0.24 better than the analyst estimate of $0.47. Revenue for the quarter came in at $286.8 million versus the consensus estimate of $278.79 million.
GUIDANCE:
Dolby Laboratories sees Q4 2021 EPS of $0.47-$0.62, versus the consensus of $0.66. Dolby Laboratories sees Q4 2021 revenue of $280-310 million, versus the consensus of $304.8 million.
For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Teck Resources (TECK) Misses Q1 EPS by 15c; reaffirms FY guidance
- Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
